DXCM
DexCom, Inc.
Healthcare · in the S&P 500 and the Nasdaq-100
📍 San Diego, United States · See it on the company map
The shape of the figures
Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.
Drag to turn the shape. Tap or point at a dot to read the figure behind it.
The figures and what each one means are below. A hollow dot means the company doesn't report that figure.
10 years from the annual reports
Source: SEC filings (10-K) ↗Revenue and profit
Revenue was $4.7bn in FY2025, against $573m in FY2016. Net profit was $836m — 18 of every 100 of revenue.
Cash the business generated
In FY2025, operations brought in $1.4bn; after $364m spent on property and equipment, $1.1bn was left (free cash flow).
As reported in each year's 10-K, in US dollars. Companies label some items differently, and a year can be missing where a figure wasn't reported in a comparable way.
Key figures, against the S&P 500
Figures as of 9 Nov 2026, refreshed weekly
Each bar places this company among the S&P 500 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.
Valuation
P/E ratio?
31.3x
The share price is 31.3 times the last twelve months' earnings per share.
P/E on average earnings?
51.6x
The share price is 51.6 times earnings per share averaged over recent years.
Price / book
11.7x
The market values the company at 11.7 times the accounting value of its equity.
EV / EBIT?
26.4x
The company's value including its debt is 26.4 times its operating profit.
Free cash flow yield?
2.7%
Free cash flow equals 2.7% of the company's market value.
Profitability
Return on equity?
37.7%
Each 100 of shareholders' money produced 37.7 of net profit.
Return on assets?
11.1%
Each 100 of assets produced 11.1 of net profit.
Return on invested capital
21.3%
Each 100 invested by lenders and owners produced 21.3 of profit.
Operating margin?
23.7%
Of every 100 in sales, 23.7 was left as operating profit.
Debt
Debt / equity?
54.9%
Total debt equals 55% of shareholders' equity.
Net debt / EBITDA?
-0.3x
The company holds more cash than debt.
Interest cover
60.5x
Operating profit was 60.5 times the interest bill.
Growth
Revenue growth
32.4%
Latest revenue is 32.4% above the average of earlier reported years.
Earnings growth
72.0%
Latest net profit is 72% above the average of earlier reported years.
⚠️ Not financial advice
This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.
This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.